Clobenpropit dihydrobromide, VUF 9153 has been shown to be an extremely potent (pA2 = 9.93) and selective histamine H3 receptor antagonist. This compound has been found to enhance the release of GABA, which protects against NMDA-induced exitotoxicity. Further experiments suggest that clobenpropit dihydrobromide my inhibit the binding of iodophenpropit, and therefor may possess the ability to cross the blood-brain barrier.
1. Yokoyama, H., et al. 1994. Eur. J. Pharmacol. 260: 23-28. PMID: 7957622
2. Harada, C., et al. 2004. Brain Res. Bull. 63: 143-146. PMID: 15130703
3. Dai, H., et al. 2007. Eur. J. Pharmacol. 563: 117-123. PMID: 17350613
4. Devi, P.U., et al. 2010. Hum Exp Toxicol. [Epub ahead of print]. PMID: 20511290